home.social

#biopharmaceuticalindustry — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #biopharmaceuticalindustry, aggregated by home.social.

  1. Yonhap Infomax News @[email protected] ·

    Celltrion reports Q1 operating profit of 149.4 billion won, up 868% year-on-year, but falls short of market expectations despite significant growth
    #YonhapInfomax #Celltrion #Q1Earnings #OperatingProfit #MarketExpectations #BiopharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #celltrion #q1earnings #operatingprofit #marketexpectations #biopharmaceuticalindustry
  2. Yonhap Infomax News @[email protected] ·

    Celltrion reports significant Q1 profit growth, but falls short of market expectations, signaling potential challenges in the biopharmaceutical sector
    #YonhapInfomax #Celltrion #Q1Earnings #OperatingProfit #BiopharmaceuticalIndustry #MarketExpectations #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #celltrion #q1earnings #operatingprofit #biopharmaceuticalindustry #marketexpectations
  3. Yonhap Infomax News @[email protected] ·

    Korea Investors Service upgrades Samsung Biologics' credit rating to 'AA', citing enhanced business competitiveness, expanded production capacity, and favorable order conditions
    #YonhapInfomax #SamsungBiologics #CreditRatingUpgrade #KoreaInvestorsService #BiopharmaceuticalIndustry #ProductionCapacity #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #samsungbiologics #creditratingupgrade #koreainvestorsservice #biopharmaceuticalindustry #productioncapacity
  4. Yonhap Infomax News @[email protected] ·

    Samsung Biologics secures major $5.7 billion contract manufacturing deal with US pharmaceutical firm, boosting its position in the global biopharmaceutical market
    #YonhapInfomax #SamsungBiologics #ContractManufacturing #USPharmaceutical #BiopharmaceuticalIndustry #StockPrice #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #samsungbiologics #contractmanufacturing #uspharmaceutical #biopharmaceuticalindustry #stockprice
  5. Yonhap Infomax News @[email protected] ·

    Samsung Biologics accelerates expansion strategy in production capacity, portfolio, and global presence as it marks 14th anniversary, with plans to increase total capacity to 1,324,000 liters by 2032.
    #YonhapInfomax #SamsungBiologics #ProductionCapacity #PortfolioDiversification #GlobalExpansion #BiopharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #samsungbiologics #productioncapacity #portfoliodiversification #globalexpansion #biopharmaceuticalindustry